搜索结果：lymphoma

Vision transformers (ViT) have been shown to allow for more flexible feature detection and can outperform convolutional neural network (CNN) when pre-trained on sufficient data. Due to their promising feature detection capabilities, we deployed ViTs for morphological classification of anaplastic large cell lymphoma (ALCL) versus classic Hodgkin lymphoma (cHL). We had previously designed a ViT model which was trained on a small dataset of 1,200 image patches in fully supervised training. That model achieved a diagnostic accuracy of 100% and an F1 score of 1.0 on the independent test set. Since fully supervised training is not a practical method due to lack of expertise resources in both the training and testing phases, we conducted a recent study on a modified approach to training data (weakly supervised training) and show that labeling training image patch automatically at the slide level of each whole-slide-image is a more practical solution for clinical use of Vision Transformer. Our ViT model, trained on a larger dataset of 100,000 image patches, yields evaluation metrics with significant accuracy, F1 score, and area under the curve (AUC) at 91.85%, 0.92, and 0.98, respectively.

This study integrates PET metabolic information with CT anatomical structures to establish a 3D multimodal segmentation dataset for lymphoma based on whole-body FDG PET/CT examinations, which bridges the gap of the lack of standardised multimodal segmentation datasets in the field of haematological malignancies. We retrospectively collected 483 examination datasets acquired between March 2011 and May 2024, involving 220 patients (106 non-Hodgkin lymphoma, 42 Hodgkin lymphoma); all data underwent ethical review and were rigorously de-identified. Complete 3D structural information was preserved during data acquisition, preprocessing and annotation, and a high-quality dataset was constructed based on the nnUNet format. By systematic technical validation and evaluation of the preprocessing process, annotation quality and automatic segmentation algorithm, the deep learning model trained based on this dataset is verified to achieve accurate segmentation of lymphoma lesions in PET/CT images with high accuracy, good robustness and reproducibility, which proves the applicability and stability of this dataset in accurate segmentation and quantitative analysis. The deep fusion of PET/CT image

Lymphoma diagnosis, particularly distinguishing between subtypes, is critical for effective treatment but remains challenging due to the subtle morphological differences in histopathological images. This study presents a novel hybrid deep learning framework that combines DenseNet201 for feature extraction with a Dense Neural Network (DNN) for classification, optimized using the Harris Hawks Optimization (HHO) algorithm. The model was trained on a dataset of 15,000 biopsy images, spanning three lymphoma subtypes: Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma (FL), and Mantle Cell Lymphoma (MCL). Our approach achieved a testing accuracy of 99.33\%, demonstrating significant improvements in both accuracy and model interpretability. Comprehensive evaluation using precision, recall, F1-score, and ROC-AUC underscores the model's robustness and potential for clinical adoption. This framework offers a scalable solution for improving diagnostic accuracy and efficiency in oncology.

To evaluate how partial volume correction (PVC) affects the reproducibility of 18F-FDG PET radiomic features in lymphoma lesions, with respect to lesion volume and tissue type. This single-center retrospective study included 131 newly diagnosed lymphoma patients who underwent baseline 18F-FDG PET/CT. In total, 1,603 lesions (1,302 lymph nodes, 117 spleen/liver, 150 bone, and 34 bone/soft-tissue) were semi-automatically segmented and grouped by volume (<3, 3-10, 10-30, >30 mL) and tissue type. 93 radiomic features were extracted from non-PVC and PVC images processed with the Richardson-Lucy (RL) and Reblurred Van Cittert (RVC) algorithms following IBSI guidelines. Reproducibility was quantified using the coefficient of variation (CoV) and the intraclass correlation coefficient (ICC2, absolute agreement), with statistical comparisons performed via Mann-Whitney U tests and false-discovery-rate (FDR) correction. PVC significantly improved feature reproducibility, particularly for large lesions (>30 mL), with median ICC2>0.90 across most feature categories. Small lesions (<3 mL) showed lower stability (ICC2=0.84-0.94) and higher CoV (0.09-0.21). First-Order and GLCM featu

Recently, vision transformers were shown to be capable of outperforming convolutional neural networks when pretrained on sufficiently large datasets. Vision transformer models show good accuracy on large scale datasets, with features of multi-modal training. Due to their promising feature detection, we aim to explore vision transformer models for diagnosis of anaplastic large cell lymphoma versus classical Hodgkin lymphoma using pathology whole slide images of HE slides. We compared the classification performance of the vision transformer to our previously designed convolutional neural network on the same dataset. The dataset includes whole slide images of HE slides for 20 cases, including 10 cases in each diagnostic category. From each whole slide image, 60 image patches having size of 100 by 100 pixels and at magnification of 20 were obtained to yield 1200 image patches, from which 90 percent were used for training, 9 percent for validation, and 10 percent for testing. The test results from the convolutional neural network model had previously shown an excellent diagnostic accuracy of 100 percent. The test results from the vision transformer model also showed a comparable accurac

Purpose: To develop a fully automated deep learning system, AutoLugano, for end-to-end lymphoma classification by performing lesion segmentation, anatomical localization, and automated Lugano staging from baseline FDG-PET/CT scans. Methods: The AutoLugano system processes baseline FDG-PET/CT scans through three sequential modules:(1) Anatomy-Informed Lesion Segmentation, a 3D nnU-Net model, trained on multi-channel inputs, performs automated lesion detection (2) Atlas-based Anatomical Localization, which leverages the TotalSegmentator toolkit to map segmented lesions to 21 predefined lymph node regions using deterministic anatomical rules; and (3) Automated Lugano Staging, where the spatial distribution of involved regions is translated into Lugano stages and therapeutic groups (Limited vs. Advanced Stage).The system was trained on the public autoPET dataset (n=1,007) and externally validated on an independent cohort of 67 patients. Performance was assessed using accuracy, sensitivity, specificity, F1-scorefor regional involvement detection and staging agreement. Results: On the external validation set, the proposed model demonstrated robust performance, achieving an overall accura

Cellular immunotherapies are one of the mainstream cancer treatments unveiling the power of the patient's immune system to fight tumors. CAR T-cell therapy, based on genetically engineered T cells, has demonstrated significant potential in treating hematological malignancies, including B-cell lymphomas. This treatment has complex longitudinal dynamics due to the interplay of different T-cell phenotypes (e.g. effector and memory), the expansion of the drug and the cytotoxic effect on both normal and cancerous B-cells, the exhaustion of the immune cells, the tumor immunosupressive environments, and more. Thus, the outcome of the therapy is not yet well understood leading to a variety of responses ranging from sustained complete responses, different types of partial responses, or no response at all. We developed a mechanistic model for the interaction between CAR T- and cancerous B-cells, accounting for the role of the tumor morphology and metabolic status. The simulations showed that lesions with irregular shapes and high proliferation could contribute to long term progression by potentially increasing their immunosuppressive capabilities impairing CAR T-cell efficacy. We analyzed 18

CAR-T cell therapies have demonstrated significant success in treating B-cell leukemia in children and young adults. However, their effectiveness in treating B-cell lymphomas has been limited. Unlike leukemia, lymphoma often manifests as solid masses of cancer cells in lymph nodes, glands, or organs, making these tumors harder to access thus hindering treatment response. In this paper we present a mathematical model that elucidates the dynamics of diffuse large B-cell lymphoma and CAR-T cells in a lymph node. The mathematical model aids in understanding the complex interplay between the cell populations involved and proposes ways to identify potential underlying dynamical causes of treatment failure. We also study the phenomenon of immunosuppression induced by tumor cells and theoretically demonstrate its impact on cell dynamics. Through the examination of various response scenarios, we underscore the significance of product characteristics in treatment outcomes.

Early cancer detection is crucial for improving patient outcomes, and 18F FDG PET/CT imaging plays a vital role by combining metabolic and anatomical information. Accurate lesion detection remains challenging due to the need to identify multiple lesions of varying sizes. In this study, we investigate the effect of adding anatomy prior information to deep learning-based lesion detection models. In particular, we add organ segmentation masks from the TotalSegmentator tool as auxiliary inputs to provide anatomical context to nnDetection, which is the state-of-the-art for lesion detection, and Swin Transformer. The latter is trained in two stages that combine self-supervised pre-training and supervised fine-tuning. The method is tested in the AutoPET and Karolinska lymphoma datasets. The results indicate that the inclusion of anatomical priors substantially improves the detection performance within the nnDetection framework, while it has almost no impact on the performance of the vision transformer. Moreover, we observe that Swin Transformer does not offer clear advantages over conventional convolutional neural network (CNN) encoders used in nnDetection. These findings highlight the cr

Malignant lymphoma subtype classification directly impacts treatment strategies and patient outcomes, necessitating classification models that achieve both high accuracy and sufficient explainability. This study proposes a novel explainable Multi-Instance Learning (MIL) framework that identifies subtype-specific Regions of Interest (ROIs) from Whole Slide Images (WSIs) while integrating cell distribution characteristics and image information. Our framework simultaneously addresses three objectives: (1) indicating appropriate ROIs for each subtype, (2) explaining the frequency and spatial distribution of characteristic cell types, and (3) achieving high-accuracy subtyping by leveraging both image and cell-distribution modalities. The proposed method fuses cell graph and image features extracted from each patch in the WSI using a Mixture-of-Experts (MoE) approach and classifies subtypes within an MIL framework. Experiments on a dataset of 1,233 WSIs demonstrate that our approach achieves state-of-the-art accuracy among ten comparative methods and provides region-level and cell-level explanations that align with a pathologist's perspectives.

We propose a method for representing malignant lymphoma pathology images, from high-resolution cell nuclei to low-resolution tissue images, within a single hyperbolic space using self-supervised learning. To capture morphological changes that occur across scales during disease progression, our approach embeds tissue and corresponding nucleus images close to each other based on inclusion relationships. Using the Poincaré ball as the feature space enables effective encoding of this hierarchical structure. The learned representations capture both disease state and cell type variations.

Lymphomas are a large group of neoplasms developed from lymphoid cells (LCs) in lymph nodes (LNs) or lymphoid tissues (LTs). Some forms of lymphomas, including Burkitt lymphoma (BL), ALK+ anaplastic large cell lymphoma (ALK+-ALCL), and T-cell lymphoblastic lymphoma/leukemia (T-LBL), occur mainly in children and teenagers. Hodgkin's lymphoma (HL) has a peak incidence at age 20s. To understand pediatric lymphoma, we have recently proposed two hypotheses on the causes and the mechanism of cell transformation of a LC. Hypothesis A is: repeated bone-remodeling during bone-growth and bone-repair may be a source of cell injuries of marrow cells including hematopoietic stem cells (HSCs), myeloid cells, and LCs, and thymic involution may be a source of damage to the developing T-cells in thymus. Hypothesis B is: a LC may have three pathways on transformation: a slow, a rapid, and an accelerated. In this paper, we discuss pediatric lymphomas by this hypothesis. Having a peak incidence at young age, BL, T-LBL, ALK+-ALCL, and HL develop more likely as a result of rapid transformation of a LC. In BL, ALK+-ALCL, and HL, the cell transformations may be triggered by severe viral infections. In T-L

The accurate classification of lymphoma subtypes using hematoxylin and eosin (H&E)-stained tissue is complicated by the wide range of morphological features these cancers can exhibit. We present LymphoML - an interpretable machine learning method that identifies morphologic features that correlate with lymphoma subtypes. Our method applies steps to process H&E-stained tissue microarray cores, segment nuclei and cells, compute features encompassing morphology, texture, and architecture, and train gradient-boosted models to make diagnostic predictions. LymphoML's interpretable models, developed on a limited volume of H&E-stained tissue, achieve non-inferior diagnostic accuracy to pathologists using whole-slide images and outperform black box deep-learning on a dataset of 670 cases from Guatemala spanning 8 lymphoma subtypes. Using SHapley Additive exPlanation (SHAP) analysis, we assess the impact of each feature on model prediction and find that nuclear shape features are most discriminative for DLBCL (F1-score: 78.7%) and classical Hodgkin lymphoma (F1-score: 74.5%). Finally, we provide the first demonstration that a model combining features from H&E-stained tissue w

$\textbf{Purpose}$: Automatic quantification of longitudinal changes in PET scans for lymphoma patients has proven challenging, as residual disease in interim-therapy scans is often subtle and difficult to detect. Our goal was to develop a longitudinally-aware segmentation network (LAS-Net) that can quantify serial PET/CT images for pediatric Hodgkin lymphoma patients. $\textbf{Materials and Methods}$: This retrospective study included baseline (PET1) and interim (PET2) PET/CT images from 297 patients enrolled in two Children's Oncology Group clinical trials (AHOD1331 and AHOD0831). LAS-Net incorporates longitudinal cross-attention, allowing relevant features from PET1 to inform the analysis of PET2. Model performance was evaluated using Dice coefficients for PET1 and detection F1 scores for PET2. Additionally, we extracted and compared quantitative PET metrics, including metabolic tumor volume (MTV) and total lesion glycolysis (TLG) in PET1, as well as qPET and $Δ$SUVmax in PET2, against physician measurements. We quantified their agreement using Spearman's $ρ$ correlations and employed bootstrap resampling for statistical analysis. $\textbf{Results}$: LAS-Net detected residual ly

This study investigates the incidence and age at diagnosis of Non-Hodgkin Lymphoma (NHL) among missileers stationed at Malmstrom Air Force Base (MAFB) compared to national benchmarks. The analysis was motivated by reports of elevated cancer diagnoses within the Intercontinental Ballistic Missile (ICBM) community, specifically targeting NHL cases due to initial media focus and data collection through the Torchlight Initiative. The methodology integrates simulation-based estimation of expected diagnoses using incomplete data and expert knowledge on the underlying population. Statistical tests, including the Standardized Incidence Ratio (SIR) and a nonparametric Sign Test, were used to evaluate both the rate of diagnosis and age at diagnosis. The results demonstrate a statistically significant increase in NHL diagnoses among missileers in the later decades, with observed rates surpassing expected benchmarks. The study also finds that the median age of diagnosis is significantly younger for the study population compared to national averages. Key methodological contributions include estimating the population size and service start ages when comprehensive cohort data is unavailable, inco

This study addresses critical gaps in automated lymphoma segmentation from PET/CT images, focusing on issues often overlooked in existing literature. While deep learning has been applied for lymphoma lesion segmentation, few studies incorporate out-of-distribution testing, raising concerns about model generalizability across diverse imaging conditions and patient populations. We highlight the need to compare model performance with expert human annotators, including intra- and inter-observer variability, to understand task difficulty better. Most approaches focus on overall segmentation accuracy but overlook lesion-specific measures important for precise lesion detection and disease quantification. To address these gaps, we propose a clinically relevant framework for evaluating deep segmentation networks. Using this lesion measure-specific evaluation, we assess the performance of four deep networks (ResUNet, SegResNet, DynUNet, and SwinUNETR) across 611 cases from multi-institutional datasets, covering various lymphoma subtypes and lesion characteristics. Beyond standard metrics like the Dice similarity coefficient, we evaluate clinical lesion measures and their prediction errors. W

Automated slice classification is clinically relevant since it can be incorporated into medical image segmentation workflows as a preprocessing step that would flag slices with a higher probability of containing tumors, thereby directing physicians attention to the important slices. In this work, we train a ResNet-18 network to classify axial slices of lymphoma PET/CT images (collected from two institutions) depending on whether the slice intercepted a tumor (positive slice) in the 3D image or if the slice did not (negative slice). Various instances of the network were trained on 2D axial datasets created in different ways: (i) slice-level split and (ii) patient-level split; inputs of different types were used: (i) only PET slices and (ii) concatenated PET and CT slices; and different training strategies were employed: (i) center-aware (CAW) and (ii) center-agnostic (CAG). Model performances were compared using the area under the receiver operating characteristic curve (AUROC) and the area under the precision-recall curve (AUPRC), and various binary classification metrics. We observe and describe a performance overestimation in the case of slice-level split as compared to the patie

Determining lymphoma subtypes is a crucial step for better patient treatment targeting to potentially increase their survival chances. In this context, the existing gold standard diagnosis method, which relies on gene expression technology, is highly expensive and time-consuming, making it less accessibility. Although alternative diagnosis methods based on IHC (immunohistochemistry) technologies exist (recommended by the WHO), they still suffer from similar limitations and are less accurate. Whole Slide Image (WSI) analysis using deep learning models has shown promising potential for cancer diagnosis, that could offer cost-effective and faster alternatives to existing methods. In this work, we propose a vision transformer-based framework for distinguishing DLBCL (Diffuse Large B-Cell Lymphoma) cancer subtypes from high-resolution WSIs. To this end, we introduce a multi-modal architecture to train a classifier model from various WSI modalities. We then leverage this model through a knowledge distillation process to efficiently guide the learning of a mono-modal classifier. Our experimental study conducted on a lymphoma dataset of 157 patients shows the promising performance of our m

Background: Accurate segmentation of diffuse large B-cell lymphoma (DLBCL) lesions is challenging due to their complex patterns in medical imaging. Objective: This study aims to develop a precise segmentation method for DLBCL using 18F-Fluorodeoxyglucose (FDG) positron emission tomography (PET) and computed tomography (CT) images. Methods: We propose a 3D dual-branch encoder segmentation method using shifted window transformers and a Multi-Scale Information Fusion (MSIF) module. To enhance feature integration, the MSIF module performs multi-scale feature fusion using cross-attention mechanisms with a shifted window framework. A gated neural network within the MSIF module dynamically balances the contributions from each modality. The model was optimized using the Dice Similarity Coefficient (DSC) loss function. Additionally, we computed the total metabolic tumor volume (TMTV) and performed statistical analyses. Results: The model was trained and validated on a dataset of 165 DLBCL patients using 5-fold cross-validation, achieving a DSC of 0.7512. Statistical analysis showed a significant improvement over comparative methods (p < 0.05). Additionally, a Pearson correlation coeffici